Home zacks
 

Keywords :   


Tag: zacks

Boston Beer Co Inc (SAM) Cut to "Sell" at Zacks Investment Research

2016-02-02 06:12:00| Beverages - Topix.net

According to Zacks, "Boston Beer reported better-than-expected earnings per share and revenues for third-quarter 2015 backed by a rise in core shipments, higher gross margin and lower taxes. The company's consistent brand building efforts and initiatives to add products to its beer, malt and cider businesses have been key revenue drivers.

Tags: research sell cut investment

 

CAE, Inc. (CAE) Stock Rating Upgraded by Zacks Investment Research

2016-02-02 03:49:32| Industrial Machines - Topix.net

According to Zacks, "CAE is a world leader in providing simulation and modelling technologies, and integrated training services to the civil aviation industry and defence forces around the globe. The Company design, manufacture and supply simulation equipment and offer training and services.

Tags: research rating stock investment

 
 

Zacks Investment Research Reaffirms "Hold" Rating for Rackspace Hosting, Inc.

2016-02-01 17:46:42| IT Services - Topix.net

's stock had its "hold" rating reiterated by Zacks Investment Research in a report issued on Monday, MarketBeat Ratings reports. According to Zacks, "As the world's leader and specialist in hosting, Rackspace Hosting is changing the way businesses worldwide buy IT.

Tags: inc research rating hold

 

Oshkosh Co. (OSK) Rating Increased to Hold at Zacks Investment Research

2016-02-01 11:47:21| Automakers - Topix.net

According to Zacks, "Oshkosh Corporation is a leading designer, manufacturer and marketer of a broad range of specialty access equipment, commercial, fire & emergency and military vehicles and vehicle bodies. Oshkosh Corporation manufactures, distributes and services products under the brands of Oshkosh, JLG, Pierce, McNeilus, Medtec, Jerr-Dan, BAI, Oshkosh Specialty Vehicles, Frontline, SMIT, Geesink, Norba, Kiggen, Con-E-Co, London and IMT.

Tags: research rating hold increased

 

Zacks Investment Research Reaffirms "Buy" Rating for OncoGenex Pharmaceuticals Inc

2016-02-01 10:16:39| Biotech - Topix.net

's stock had its "buy" rating restated by Zacks Investment Research in a report released on Sunday, AnalystRatingsNetwork.com reports. They currently have a $0.75 target price on the biopharmaceutical company's stock.

Tags: inc buy research rating

 

Sites : [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] next »